Factors predictive of survival in advanced laryngeal cancer

Amy Y. Chen, Michael Halpern

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

Objective: To determine the factors predictive of improved survival among patients with advanced laryngeal cancer. Design: National hospital-based cancer registry. Patients: Patients treated with total laryngectomy (TL), radiation therapy alone (RT), or combined chemotherapy and radiation therapy (chemo-RT). Results: Of the 10 590 patients meeting the initial inclusion criteria, 7019 had appropriate nonmissing values in all study variables and were included in the analysis. Overall, TL was significantly associated with increased likelihood of survival compared with RT or chemo-RT (P<.001). Among patients with stage III cancer, TL and chemo-RT had similar impacts on survival (each showed increased survival compared with RT), whereas TL was associated with significantly greater survival than chemo-RT or RT among patients with stage IV disease (P<.001). Overall survival was also decreased among men, black patients (compared with white patients), and patients with Medicare or Medicaid or those who were uninsured (compared with those with private insurance). Conclusions: Among patients with the most advanced disease (stage IV), TL was associated with increased survival compared with chemo-RT or RT, whereas both TL and chemo-RT improved survival over RT among patients with stage III cancer. Insurance type and black race also showed significant associations with survival, which may reflect barriers in access to care (P<.001).

Original languageEnglish (US)
Pages (from-to)1270-1276
Number of pages7
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume133
Issue number12
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Laryngeal Neoplasms
Radiotherapy
Laryngectomy
Survival
Drug Therapy
Insurance
Hospital Design and Construction
Cancer Care Facilities
Medicaid
Medicare
Registries
Neoplasms

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Factors predictive of survival in advanced laryngeal cancer. / Chen, Amy Y.; Halpern, Michael.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 133, No. 12, 12.2007, p. 1270-1276.

Research output: Contribution to journalArticle

@article{c02b3f3f32864571ab6a6d8df52fc4fd,
title = "Factors predictive of survival in advanced laryngeal cancer",
abstract = "Objective: To determine the factors predictive of improved survival among patients with advanced laryngeal cancer. Design: National hospital-based cancer registry. Patients: Patients treated with total laryngectomy (TL), radiation therapy alone (RT), or combined chemotherapy and radiation therapy (chemo-RT). Results: Of the 10 590 patients meeting the initial inclusion criteria, 7019 had appropriate nonmissing values in all study variables and were included in the analysis. Overall, TL was significantly associated with increased likelihood of survival compared with RT or chemo-RT (P<.001). Among patients with stage III cancer, TL and chemo-RT had similar impacts on survival (each showed increased survival compared with RT), whereas TL was associated with significantly greater survival than chemo-RT or RT among patients with stage IV disease (P<.001). Overall survival was also decreased among men, black patients (compared with white patients), and patients with Medicare or Medicaid or those who were uninsured (compared with those with private insurance). Conclusions: Among patients with the most advanced disease (stage IV), TL was associated with increased survival compared with chemo-RT or RT, whereas both TL and chemo-RT improved survival over RT among patients with stage III cancer. Insurance type and black race also showed significant associations with survival, which may reflect barriers in access to care (P<.001).",
author = "Chen, {Amy Y.} and Michael Halpern",
year = "2007",
month = "12",
doi = "10.1001/archotol.133.12.1270",
language = "English (US)",
volume = "133",
pages = "1270--1276",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Factors predictive of survival in advanced laryngeal cancer

AU - Chen, Amy Y.

AU - Halpern, Michael

PY - 2007/12

Y1 - 2007/12

N2 - Objective: To determine the factors predictive of improved survival among patients with advanced laryngeal cancer. Design: National hospital-based cancer registry. Patients: Patients treated with total laryngectomy (TL), radiation therapy alone (RT), or combined chemotherapy and radiation therapy (chemo-RT). Results: Of the 10 590 patients meeting the initial inclusion criteria, 7019 had appropriate nonmissing values in all study variables and were included in the analysis. Overall, TL was significantly associated with increased likelihood of survival compared with RT or chemo-RT (P<.001). Among patients with stage III cancer, TL and chemo-RT had similar impacts on survival (each showed increased survival compared with RT), whereas TL was associated with significantly greater survival than chemo-RT or RT among patients with stage IV disease (P<.001). Overall survival was also decreased among men, black patients (compared with white patients), and patients with Medicare or Medicaid or those who were uninsured (compared with those with private insurance). Conclusions: Among patients with the most advanced disease (stage IV), TL was associated with increased survival compared with chemo-RT or RT, whereas both TL and chemo-RT improved survival over RT among patients with stage III cancer. Insurance type and black race also showed significant associations with survival, which may reflect barriers in access to care (P<.001).

AB - Objective: To determine the factors predictive of improved survival among patients with advanced laryngeal cancer. Design: National hospital-based cancer registry. Patients: Patients treated with total laryngectomy (TL), radiation therapy alone (RT), or combined chemotherapy and radiation therapy (chemo-RT). Results: Of the 10 590 patients meeting the initial inclusion criteria, 7019 had appropriate nonmissing values in all study variables and were included in the analysis. Overall, TL was significantly associated with increased likelihood of survival compared with RT or chemo-RT (P<.001). Among patients with stage III cancer, TL and chemo-RT had similar impacts on survival (each showed increased survival compared with RT), whereas TL was associated with significantly greater survival than chemo-RT or RT among patients with stage IV disease (P<.001). Overall survival was also decreased among men, black patients (compared with white patients), and patients with Medicare or Medicaid or those who were uninsured (compared with those with private insurance). Conclusions: Among patients with the most advanced disease (stage IV), TL was associated with increased survival compared with chemo-RT or RT, whereas both TL and chemo-RT improved survival over RT among patients with stage III cancer. Insurance type and black race also showed significant associations with survival, which may reflect barriers in access to care (P<.001).

UR - http://www.scopus.com/inward/record.url?scp=37349128341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349128341&partnerID=8YFLogxK

U2 - 10.1001/archotol.133.12.1270

DO - 10.1001/archotol.133.12.1270

M3 - Article

C2 - 18086971

AN - SCOPUS:37349128341

VL - 133

SP - 1270

EP - 1276

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 12

ER -